Skip to main content
HeartCited

Coenzyme Q10 (CoQ10) ： Heart Failure

B エビデンス 少なくとも1件のランダム化試験がこれを支持しており、おおむね一貫した結果が得られています。

Q-SYMBIO trial (420 patients, 2 years): 43% MACE reduction, 44% CV mortality reduction with 300 mg/day. Multiple meta-analyses support improved exercise tolerance and ejection fraction.

B

結論

Q-SYMBIO trial (420 patients, 2 years): 43% MACE reduction, 44% CV mortality reduction with 300 mg/day. Multiple meta-analyses support improved exercise tolerance and ejection fraction.

Key Study Findings

Randomized Controlled Trial 52.0 weeks Double-blind
Coenzyme Q10 in health and disease.
Dose: 200 mg Outcome: liver function 効果: or 6

対象集団: cardiac patients

Key Statistics

15

研究数

1500

参加者数

↑

Positive

B

グレード

Referenced Papers

Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality. Review
Current cardiology reports 2023 8 件の引用
Depletion and Supplementation of Coenzyme Q10 in Secondary Deficiency Disorders. Review
Frontiers in bioscience … 2022 11 件の引用
Coenzyme Q10. Review
Methodist DeBakey cardiovascular … 2019 53 件の引用
Coenzyme Q10 and Heart Failure: A State-of-the-Art Review. Review
Circulation. Heart failure 2016 114 件の引用
Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement? Review
Current heart failure … 2016 18 件の引用
Coenzyme Q10 in health and disease. Review
European journal of … 1999 230 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
100-200 mg/day
statinsupport:
100-300 mg/day
heartfailuresupport:
100-300 mg/day (ubiquinol form preferred)

上限量： 1,200 mg/day (well-tolerated in clinical trials)

研究で検討された用量

用量 期間 効果 N
200 mg 52.0 weeks Neutral --

推奨摂取タイミング： With meals containing fat; ubiquinol form has 2-3x better bioavailability than ubiquinone

Safety & Side Effects

報告されている副作用

  • ⚠ Mild gastrointestinal discomfort (nausea, diarrhea)
  • ⚠ Insomnia (rare, if taken late in the day)
  • ⚠ Headache (rare)
  • ⚠ May lower blood sugar slightly

既知の相互作用

  • ● Warfarin (may reduce anticoagulant efficacy due to structural similarity to vitamin K)
  • ● Blood pressure medications (additive hypotensive effect)
  • ● Statins (may alleviate statin-associated muscle symptoms)
  • ● Insulin and oral hypoglycemics (additive blood sugar lowering)

耐容上限摂取量： 1,200 mg/day (well-tolerated in clinical trials)

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Coenzyme Q10 (CoQ10) help with Heart Failure?
Based on 15 studies with 1,500 participants, there is moderate evidence from clinical studies that Coenzyme Q10 (CoQ10) may support Heart Failure management. Our evidence grade is B (Good Evidence).
How much Coenzyme Q10 (CoQ10) should I take for Heart Failure?
Studies have used various dosages. A commonly studied range is 100-200 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Coenzyme Q10 (CoQ10)?
Reported side effects may include Mild gastrointestinal discomfort (nausea, diarrhea), Insomnia (rare, if taken late in the day), Headache (rare), May lower blood sugar slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Coenzyme Q10 (CoQ10) and Heart Failure?
We rate the evidence as Grade B (Good Evidence). This rating is based on 15 peer-reviewed studies with 1,500 total participants. The overall direction of effect is positive.

Coenzyme Q10 (CoQ10) 他の症状・状態について

High Blood Pressure (Hypertension) B Cardiac Arrhythmia C

Embed This Widget

Style



      
      
    


    
    

      Widget powered by
      .
      Free, no account required.
    

  










  
References

  
    
    
    
  1. 
      [1]
      Johannes-Paul Fladerer et al..
      Curr Cardiol Rep.
      2023.
      Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality.
      doi:10.1007/s11886-023-01992-6
      PubMed
    
    2. 
    
    
  2. 
      [2]
      David Mantle et al..
      Front Biosci (Landmark Ed).
      2022.
      Depletion and Supplementation of Coenzyme Q10 in Secondary Deficiency Disorders.
      doi:10.31083/j.fbl2712322
      PubMed
    
    3. 
    
    
  3. 
      [3]
      Albert E Raizner.
      Methodist Debakey Cardiovasc J.
      2019.
      Coenzyme Q10.
      doi:10.14797/mdcj-15-3-185
      PubMed
    
    4. 
    
    
  4. 
      [4]
      Abhinav Sharma et al..
      Circ Heart Fail.
      2016.
      Coenzyme Q10 and Heart Failure: A State-of-the-Art Review.
      doi:10.1161/CIRCHEARTFAILURE.115.002639
      PubMed
    
    5. 
    
    
  5. 
      [5]
      Sylvia Oleck et al..
      Curr Heart Fail Rep.
      2016.
      Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement?
      doi:10.1007/s11897-016-0296-6
      PubMed
    
    6. 
    
    
  6. 
      [6]
      K Overvad et al..
      Eur J Clin Nutr.
      1999.
      Coenzyme Q10 in health and disease.
      doi:10.1038/sj.ejcn.1600880
      PubMed
    
    7. 
    
  















    

        FDAに関する免責事項:
        これらの記述は米国食品医薬品局（FDA）による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。